MORRISVILLE,Respirics, which has developed a dry-power inhaler as an alternative for people who want or need an alterative to existing inhalers, will work with TEAMM Pharmaceuticals to license and sell the product.

TEAMM will use its existing sales force to drive sales, the companies said in a statement.

Respirics is focused on ways to improve the efficiency of drug delivery.